लोड हो रहा है...
Adoption of Sacubitril/Valsartan for the Management of Patients with Heart Failure
BACKGROUND: The United States Food and Drug Administration (FDA) approved the use of sacubitril/valsartan in patients with heart failure (HF) and reduced ejection fraction (HFrEF) in July 2015We aimed to assess the adoption and prescription drug costs of sacubitril/valsartan in its first 18 months f...
में बचाया:
| में प्रकाशित: | Circ Heart Fail |
|---|---|
| मुख्य लेखकों: | , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2018
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5820776/ https://ncbi.nlm.nih.gov/pubmed/29453287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCHEARTFAILURE.117.004302 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|